Welcome to our dedicated page for Cerence SEC filings (Ticker: CRNC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Cerence Inc. (NASDAQ: CRNC) SEC filings page brings together the company’s regulatory disclosures, including current reports on Form 8-K and other documents filed with the U.S. Securities and Exchange Commission. As a software company focused on conversational AI for automotive and transportation, Cerence uses its SEC filings to report material events, financial results, restructuring actions, and significant agreements.
Investors can use this page to access 8-K filings that announce quarterly and annual financial results, as well as presentations used on earnings calls. These filings often include discussions of revenue from software licenses and cloud-connected services, key performance indicators such as the percentage of worldwide auto production with Cerence technology, and commentary on the company’s AI platforms and product adoption. Other 8-Ks describe material events such as restructuring plans related to certain foreign operations, retention and equity award arrangements for senior executives, and notable transactions.
Cerence has also filed 8-Ks detailing the resolution of patent disputes and the execution of a cross-license agreement with Samsung, which resulted in a one-time lump sum payment, and disclosing the announcement of financial results for specific periods. These documents provide insight into the company’s intellectual property strategy and its approach to monetizing and protecting its technology.
On Stock Titan, SEC filings for CRNC are updated as they become available from EDGAR. AI-powered tools can help summarize lengthy disclosures, highlight key sections in annual and quarterly reports, and surface important items such as restructuring charges, executive compensation arrangements, and material agreements. Users interested in Cerence’s regulatory history, financial condition, and corporate actions can review 10-Ks, 10-Qs, 8-Ks, and other forms here, and use AI summaries to quickly understand the implications of each filing.
Matus Kristi Ann reported acquisition or exercise transactions in a Form 4 filing for CRNC. The filing lists transactions totaling 12,968 shares at a weighted average price of $0.01 per share. Following the reported transactions, holdings were 54,737 shares.
Cerence Inc. director Marianne Budnik received a new equity award in the form of restricted stock units (RSUs). On 02/12/2026, she acquired 12,968 shares of common stock at a grant price of $0.01 per share, increasing her directly held stake to 60,166 shares.
The RSUs will vest on the earlier of the first anniversary of the grant date or the day immediately before Cerence's next fiscal year Annual General Meeting, aligning the award with both time-based service and the company’s annual shareholder meeting cycle.
Cerence Inc. director Douglas Lee Davis acquired 12,968 shares of common stock as a restricted stock unit award on February 12, 2026 at a price of $0.01 per share. Following this grant, he directly beneficially owns 39,544 common shares.
The RSUs will vest on the earlier of the first anniversary of the grant date or the day immediately before Cerence’s next fiscal year Annual General Meeting, aligning the director’s compensation with future company performance.
Cerence Inc. director Marcy S. Klevorn received an equity award of 12,968 shares of common stock at $0.01 per share on 02/12/2026. The award is reported as an acquisition and appears to represent restricted stock units that convert into common shares as they vest.
After this grant, Klevorn directly owns 35,404 shares of Cerence common stock. The RSUs will vest on the earlier of the first anniversary of the grant date or the day immediately before Cerence’s next fiscal-year annual general meeting, tying vesting to both time and the company’s shareholder meeting schedule.
Harris Marion reported acquisition or exercise transactions in this Form 4 filing.
Cerence Inc. director Marion Harris reported an equity award of 12,968 shares of common stock at $0.01 per share on February 12, 2026. This grant increased Harris’s directly held stake to 27,178 shares.
The award is structured as restricted stock units that will vest on the earlier of the first anniversary of the grant date or the day immediately before Cerence’s next fiscal year annual general meeting.
Cerence Inc. reported strong top-line growth for the three months ended December 31, 2025, with total revenue rising to $115.1 million from $50.9 million, driven largely by a $49.5 million one-time IP license payment from a cross-license agreement with Samsung.
License revenue jumped to $87.8 million, while connected services and professional services contributed $14.5 million and $12.8 million, respectively. Operating results improved to $29.3 million income from operations versus a prior-year loss, despite $7.8 million in restructuring and other costs and about $20.7 million of legal fees tied to the Samsung matter.
After a $35.3 million income tax provision, Cerence posted a net loss of $5.2 million, narrower than the $24.3 million loss a year earlier. Cash flow from operations strengthened to $37.9 million, cash and cash equivalents were $92.1 million, and long-term debt declined to $171.9 million following repurchases of 2028 convertible notes.
Cerence Inc. furnished an update on its recent performance by announcing financial results for the fiscal quarter ended December 31, 2025. The company issued a press release and an accompanying investor presentation on February 4, 2026, both of which include detailed financial data and non-GAAP measures.
The materials, filed as Exhibits 99.1 and 99.2, also provide reconciliations between GAAP and non-GAAP figures and explain why these non-GAAP metrics are used. This information is furnished under a current report, meaning it is not treated as being formally filed for certain liability purposes.
Cerence Inc. chief executive officer Brian M. Krzanich reported an equity award of 263,338 shares of common stock on January 9, 2026. The filing shows these shares at a reference price of $12.35 per share and indicates he beneficially owned 1,722,091 shares of Cerence common stock after this grant, held directly.
According to a footnote, the award is structured as restricted stock units under a Restricted Stock Unit Agreement. The units are scheduled to vest in three equal installments, with one-third of the shares vesting on each of October 1, 2026, October 1, 2027 and October 1, 2028, tying the compensation to continued service over that period.
Cerence Inc. reported that EVP and Chief Revenue Officer Christian Mentz received an award of 131,694 shares of common stock on January 9, 2026 at a price of $12.35 per share. The award is in the form of restricted stock units that vest in three equal parts on October 1, 2026, 2027, and 2028 under a Restricted Stock Unit Agreement. Following this grant, Mentz beneficially owns 293,474 shares of Cerence common stock in direct ownership.
Cerence Inc. executive Nils Schanz, EVP Product & Technology, reported receiving a grant of 87,796 shares of common stock on January 9, 2026. The filing describes this as a grant of restricted stock units under a Restricted Stock Unit Agreement at a reported price of $12.35 per share. According to the footnote, the shares vest in three equal installments, with one-third vesting on each of October 1, 2026, 2027, and 2028. After this grant, Schanz beneficially owns 342,682 shares of Cerence common stock, held directly.